Cargando…

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors

BACKGROUND/AIMS: Sirolimus (SRL) is a promising immunosuppressant replacingcalcineurin inhibitors (CNIs). This study was performed to evaluate the safetyand immunologic benefits of conversion to SRL in stable kidney transplant (KT)recipients exposed to CNIs for long periods. METHODS: Fourteen CNI-tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Ji Hyun, Kim, Kyoung Woon, Kim, Bo-Mi, Chung, Byung Ha, Cho, Mi-La, Choi, Bum Soon, Park, Cheol Whee, Kim, Yong-Soo, Yang, Chul Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855095/ https://www.ncbi.nlm.nih.gov/pubmed/26968190 http://dx.doi.org/10.3904/kjim.2014.366

Ejemplares similares

Dysregulation of Th17 Cells during the Early Post-Transplant Period in Patients under Calcineurin Inhibitor Based Immunosuppression
por: Chung, Byung Ha, et al.
Publicado: (2012)

Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients
por: Min, Ji Won, et al.
Publicado: (2016)

Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy
por: Kim, Jin Young, et al.
Publicado: (2012)

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
por: Joo, Dong Jin, et al.
Publicado: (2014)

Immunologic and non-immunologic complications of a third kidney transplantation
por: Kim, Hyun Seon, et al.
Publicado: (2015)

Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney
por: Sun, In O, et al.
Publicado: (2013)

B cell-associated immune profiles in patients with end-stage renal disease (ESRD)
por: Kim, Kyoung Woon, et al.
Publicado: (2012)

Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2015)

Clinical significance of CCR7(+)CD8(+) T cells in kidney transplant recipients with allograft rejection
por: Kim, Kyoung Woon, et al.
Publicado: (2018)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
por: Ban, Tae Hyun, et al.
Publicado: (2019)

Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients
por: Park, Hoon Suk, et al.
Publicado: (2014)

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients
por: Lee, Hae Min, et al.
Publicado: (2015)

Clinical significance of the presence of anti-human leukocyte antigen-donor specific antibody in kidney transplant recipients with allograft dysfunction
por: Chung, Byung Ha, et al.
Publicado: (2018)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
por: Park, Yohan, et al.
Publicado: (2020)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)

The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients
por: An, Gun Hee, et al.
Publicado: (2014)

The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients
por: Smith, Aaron, et al.
Publicado: (2017)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Clinical significance of CD161(+)CD4(+) T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients
por: Kim, Kyoung Woon, et al.
Publicado: (2018)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Effect of intradialytic change in blood pressure and ultrafiltration volume on the variation in access flow measured by ultrasound dilution
por: Park, Hoon Suk, et al.
Publicado: (2013)

Cytomegalovirus Induced Interstitial Nephritis and Ureteral Stenosis in Renal Transplant Recipient
por: Bae, Sung Ha, et al.
Publicado: (2012)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype
por: Carroll, Robert P., et al.
Publicado: (2013)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
por: Ban, Tae Hyun, et al.
Publicado: (2021)

Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study
por: Lee, Jong Hoon, et al.
Publicado: (2018)

Impact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort study
por: Park, Woo Yeong, et al.
Publicado: (2019)

Clinical Significance of Anti-endothelial Cell Antibody in Renal Transplant Recipients
por: Shin, Young Shin, et al.
Publicado: (2001)

Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression
por: Doh, Kyoung Chan, et al.
Publicado: (2019)

Immunological benefits by ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression
por: Heo, Seong Beom, et al.
Publicado: (2016)

Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4(+) T cell induced injury in human renal proximal tubular epithelial cells
por: Chung, Byung Ha, et al.
Publicado: (2017)

Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats
por: Jin, Jian, et al.
Publicado: (2017)

Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model
por: Sereno, José, et al.
Publicado: (2012)

Comparison of Estimating Equations for the Prediction of Glomerular Filtration Rate in Kidney Donors before and after Kidney Donation
por: Chung, Byung Ha, et al.
Publicado: (2013)

Clinical significance of red blood cell distribution width in the prediction of mortality in patients on peritoneal dialysis
por: Sun, In O., et al.
Publicado: (2016)

Malignant Hypertension with an Unusual Presentation Mimicking the Immune Mediated Pulmonary Renal Syndrome
por: Park, Hoon Suk, et al.
Publicado: (2012)

Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients
por: Lee, Yu Ho, et al.
Publicado: (2018)

A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
por: Zheng, Xiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56n61pchn8ebsgi29r1brevckd